The medical device industry is wondering what's next after the unexpected announcement from Scott Gottlieb that he is stepping down as commissioner of the Food and Drug Administration (FDA) at the end of this month. Many observers anticipate that President Donald Trump's eventual nominee to permanently replace Gottlieb could face a high-profile confirmation battle, given the highly partisan political climate. In the meantime, National Cancer Institute Director Norman Sharpless will take the reins as acting commissioner.
展开▼
